AUNA
AunaAUNA
AUNA
About: Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru and Healthcare services in Peru, Columbia and Mexico. Key revenue is generated from Peru.
Employees: 14,842
0
Funds holding %
of 7,429 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
11% more funds holding
Funds holding: 18 [Q1] → 20 (+2) [Q2]
0.4% more ownership
Funds ownership: 14.8% [Q1] → 15.2% (+0.4%) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
10% less capital invested
Capital invested by funds: $31.6M [Q1] → $28.4M (-$3.21M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for AUNA.
Financial journalist opinion
Based on 4 articles about AUNA published over the past 30 days
Neutral
Seeking Alpha
5 days ago
Auna S.A. (AUNA) Q2 2025 Earnings Call Transcript
Auna S.A. (NYSE:AUNA ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Ana Maria Mora - Head of Investor Relations Gisele Remy Ferrero - CFO & Executive VP Jesús Antonio Zamora Leon - President, CEO & Executive Chairman of the Board Conference Call Participants Artur do Amaral Alves - Morgan Stanley, Research Division Leandro Bastos - Citigroup Inc., Research Division Operator Good morning, and welcome to Auna's Second Quarter 2025 Earnings Conference Call. My name is Ellie, and I will be your operator for today's call.
Positive
Zacks Investment Research
6 days ago
Auna S.A. (AUNA) Beats Q2 Earnings Estimates
Auna S.A. (AUNA) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.03 per share a year ago.
Neutral
Business Wire
6 days ago
Auna Announces 2Q25 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the second quarter ended June 30, 2025 (“second quarter 2025” or “2Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 2Q25 Consolidated Highlights Consolidat.
Positive
Zacks Investment Research
1 week ago
Auna S.A. (AUNA) Reports Next Week: Wall Street Expects Earnings Growth
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
Business Wire
1 month ago
Auna Common Shares Begin Trading on the Lima Stock Exchange to Strengthen Company's Regional Presence and Broaden Investor Access
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced that its common shares will begin trading on the Lima Stock Exchange (“BVL”) today. This milestone is part of the Company's strategy to improve trading liquidity, strengthen its presence in Latin America´s capital markets, and expand its access to local and regional investors. Auna's common shares are now traded on bot.
Neutral
Business Wire
1 month ago
Auna Announces Reporting Dates for Second Quarter 2025 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2025 financial results. Earnings Release Tuesday, August 19, 2025 Time: After Market Close Conference Call Wednesday, August 20, 2025 Time: 8:00 a.m. ET Quiet Period Monday, August 4 through Tuesday, August 19, 2025 To participate, please dial +1 888 5.
Neutral
Business Wire
1 month ago
Auna Provides an Update From Its Controlling Shareholder Enfoca Regarding Its Sponsor-Level Financing
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today that its controlling shareholder, Enfoca Sociedad Administradora de Fondos de Inversión S.A. (“Enfoca”), has notified the Company about the status of its sponsor-level financing. According to Enfoca, its “sponsor-level financing which had a final maturity of October 5, 2025, has been successfully refinanced. The new faci.
Positive
Seeking Alpha
2 months ago
Auna: Scalable, Profitable, Misunderstood
AUNA's integrated LatAm healthcare platform is undervalued due to short-term execution, not structural flaws. The payor-provider model drives superior margins, cost efficiencies, and creates a powerful ecosystem with strong operating leverage, especially in underutilized Mexican assets. Management is actively addressing physician onboarding and payor mix, with insurance-led strategies poised to drive patient volume and profitability recovery.
Positive
Zacks Investment Research
3 months ago
Auna S.A. (AUNA) Q1 Earnings Top Estimates
Auna S.A. (AUNA) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.10 per share a year ago.
Neutral
Business Wire
3 months ago
Auna Announces 1Q25 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 (“first quarter 2025” or “1Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 1Q25 Consolidated Highlights Consolidate.
Charts implemented using Lightweight Charts™